Clinical update from ongoing MP0533 phase 1/2a dose escalation study confirms overall acceptable safety profile observed so far and initial ...

Presenters are kindly asked not to exceed the size of the board. Posters presented in the Sessions are asked to be set-up during the lunch break on the day of presentation. Posters must be taken down ...

PharmaJet Poster Presentation at Cancer Immunotherapy Conference Highlights How Needle-free Technology is Enhancing Oncology ...

To help us make on demand presentations as accessible as possible, we need your help making sure the automatic captions are accurate. Your poster is your content. The ESA meeting platform will only ...

Many academic conferences will include poster presentations as part of the event, which will provide opportunities for presenters to talk to attendees about their work with their poster as a visual ...

DIJON, France--(BUSINESS WIRE)--Regulatory News ... Professor of Gastroenterology at CHRU of Nancy. "This presentation provides strong evidence that OPM has the potential to advance the treatment ...

--(BUSINESS WIRE)--Perosphere (Perosphere Technologies ... non-medicated subjects. Oral Poster Presentation Title: Clinical Performance of a Novel Point-of-Care Coagulometer for the DOACs ...

Will present initial Phase 1C dose escalation data for vilastobart (XTX101), a tumor-activated, Fc-enhanced anti-CTLA-4, in combination with ...

November 05, 2024--(BUSINESS WIRE)--ReAlta Life Sciences ... inflammatory response to address rare and acute inflammatory ...

This presentation will emphasize efficacy and ... 2024, from 3 p.m. CET. Poster details Title: “Randomized phase I trial of adjuvant individualized TG4050 vaccine in patients with locally ...

The poster presentation details are as follows ... and Molecular Partners' expected business and financial outlook, including anticipated expenses and cash utilization for 2024 and its expectation ...